Format

Send to

Choose Destination
See comment in PubMed Commons below
Leuk Lymphoma. 2011 Nov;52(11):2045-9. doi: 10.3109/10428194.2011.584002. Epub 2011 Jun 12.

Myelodysplastic syndromes: the role of the immune system in pathogenesis.

Author information

1
Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN, USA. ewarlick@umn.edu

Abstract

The myelodysplastic syndromes (MDS) represent a complex spectrum of clonal hematopoietic stem cell disorders manifested by cytopenias, risk of infection, and variable risk of progression to acute myelogenous leukemia. Several theories of MDS pathogenesis exist, with contributions of genetic, epigenetic, apoptotic, differentiation, and cytokine milieu abnormalities. Immune dysregulation has also been implicated in MDS pathogenesis. In some forms of MDS it is evident that immune dysregulation may be a primary pathophysiologic abnormality, while in others the abnormal immune function may represent only a small part of the pathologic puzzle. We review the current literature regarding natural killer (NK) cell, T cell, and myeloid derived suppressor cell abnormalities in the spectrum of MDS.

PMID:
21663505
DOI:
10.3109/10428194.2011.584002
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center